open access

Vol 6, No 2 (2010)
Review paper
Published online: 2010-06-25
Get Citation

Frailty - an overview for oncologists

Jolanta Życzkowska, Tomasz Grądalski
Onkol. Prak. Klin 2010;6(2):79-84.

open access

Vol 6, No 2 (2010)
REVIEW ARTICLES
Published online: 2010-06-25

Abstract

Frailty syndrome defines the elderly population with chronic health care problems loosing the physical efficiency. It is a physiological syndrome consisted of the diminishing physical reserves and also decreasing resistance for the various stressors. It can lead to the social dependence and the increased risk of hospitalization, morbidity and mortality rate, even due to the trivial causes. High level of inflammatory mediators, coagulation disturbances, age related changes in hormone levels, muscle loss or sarcopenia appear to be connected with this syndrome. Clinical diagnosis consists of the weight loss, asthenia, fatigue, walking slowness and physical capacity deterioration.
Onkol. Prak. Klin. 2010; 6, 2: 79-84

Abstract

Frailty syndrome defines the elderly population with chronic health care problems loosing the physical efficiency. It is a physiological syndrome consisted of the diminishing physical reserves and also decreasing resistance for the various stressors. It can lead to the social dependence and the increased risk of hospitalization, morbidity and mortality rate, even due to the trivial causes. High level of inflammatory mediators, coagulation disturbances, age related changes in hormone levels, muscle loss or sarcopenia appear to be connected with this syndrome. Clinical diagnosis consists of the weight loss, asthenia, fatigue, walking slowness and physical capacity deterioration.
Onkol. Prak. Klin. 2010; 6, 2: 79-84
Get Citation

Keywords

frailty; pre-death syndrome; asthenia; sarcopenia; cachexia

About this article
Title

Frailty - an overview for oncologists

Journal

Oncology in Clinical Practice

Issue

Vol 6, No 2 (2010)

Article type

Review paper

Pages

79-84

Published online

2010-06-25

Bibliographic record

Onkol. Prak. Klin 2010;6(2):79-84.

Keywords

frailty
pre-death syndrome
asthenia
sarcopenia
cachexia

Authors

Jolanta Życzkowska
Tomasz Grądalski

References (32)
  1. World Health Organization.. Cancer pain relief. Wyd. 2. WHO, Geneva 1996.
  2. Stjernsward J, Pampallona S. Palliative medicine/a global perspective. In: Doyle D, Hanks GWC, Macdonald N. ed. Oxford textbook of palliative medicine. Oxford University Press, Oxford 1998.
  3. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002; 296(5570): 1029–1031.
  4. Krzemieniecki K. Całościowa ocena geriatryczna i jej znaczenie kliniczne w onkologii — systematyczny przegląd piśmiennictwa. Gerontom Pol. 2009; 17: 1.
  5. Zaslavsky O, Woods NF, LaCroix AZ, et al. Women's Health Initiative Observational Study, Women's Health Initiative, Women's Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005; 53(8): 1321–1330.
  6. Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3): 46–56.
  7. Fried LP, Walston J. Frailty and failure to thrive. In: Hazzard W, Blass JP, Halter JB. ed. Principles of Geriatric Medicine and Gerontology. Wyd 5. McGraw-Hill, New York 2003: 1487–1502.
  8. Leng SX, Cappola AR, Andersen RE, et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res. 2004; 16(2): 153–157.
  9. Rockwood K, Abeysundera MJ, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc. 2007; 8(9): 595–603.
  10. Orme JG, Reis J, Herz EJ. Factorial and discriminant validity of the Center for Epidemiological Studies Depression (CES-D) scale. J Clin Psychol. 1986; 42(1): 28–33.
  11. Taylor HL, Jacobs DR, Schucker B, et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978; 31(12): 741–755.
  12. Studenski S, Hayes RP, Leibowitz RQ, et al. Clinical Global Impression of Change in Physical Frailty: development of a measure based on clinical judgment. J Am Geriatr Soc. 2004; 52(9): 1560–1566.
  13. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173(5): 489–495.
  14. Rockwood K, Hogan D, MacKnight C. Conceptualisation and Measurement of Frailty in Elderly People. Drugs & Aging. 2000; 17(4): 295–302.
  15. Singh M, Alexander K, Roger VL, et al. Frailty and its potential relevance to cardiovascular care. Mayo Clin Proc. 2008; 83(10): 1146–1153.
  16. Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004; 59(3): M255–M263.
  17. Jaafar AF, Heycock R, George J. Frailty — a clinical overview. Clin Gerontol. 2007; 17: 171–175.
  18. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006; 54(6): 991–1001.
  19. Leng S, Chaves P, Koenig K, et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002; 50(7): 1268–1271.
  20. Walston J, McBurnie MA, Newman A, et al. Cardiovascular Health Study. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002; 162(20): 2333–2341.
  21. Leng S, Xue QL, Huang Yi, et al. Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med Sci. 2005; 60(2): 195–199.
  22. van den Biggelaar AHJ, Huizinga TWJ, de Craen AJM, et al. Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol. 2004; 39(9): 1407–1414.
  23. Morley JE, Perry HM, Miller DK. Editorial: Something about frailty. J Gerontol A Biol Sci Med Sci. 2002; 57(11): M698–M704.
  24. Kamel HK. Sarcopenia and aging. Nutr Rev. 2003; 61(5 Pt 1): 157–167.
  25. Rockwood K. Frailty and its definition: a worthy challenge. J Am Geriatr Soc. 2005; 53(6): 1069–1070.
  26. Tan BHL, Fearon KCH. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008; 11(4): 400–407.
  27. Morley JE, Thomas DR, Wilson MMG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006; 83(4): 735–743.
  28. Omlin AG, Strsser F. Anorexia and wright loss. In: Walsh D, Strsser F. ed. Palliative Medicine. Saunders Elsevier, Philadelphia 2009: 826–833.
  29. Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008; 27(6): 793–799.
  30. Mantovani G. Cancer cachexia: Medical management. ESMO Symposium Zurich, 20-21.03.2009.
  31. Faron KC. H. cachexia: Developing multimodal therapy for a multidimensional problem. Eur J Cancer. 2008; 4: 1124–1132.
  32. Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer. 2004; 90(10): 1905–1911.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl